EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+4.91%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$438M
AUM Growth
-$221K
(-0.05%)
Cap. Flow
-$8.23M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$8.03M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$201K |
Sector Composition
| 1 | Healthcare | 96.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $182M | 41.42% |
1,450,000
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $95.5M | 21.79% |
4,592,047
| – | – |
|
3
Axogen
AXGN
$753M
| $50.8M | 11.59% |
4,861,111
| – | – |
|
|
ENTL
4
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $44.6M | 10.18% |
3,231,656
-581,541
| -15% | -$8.03M |
|
|
CORI
5
DELISTED
Corium International, Inc.
CORI
| $39.1M | 8.92% |
9,353,304
| – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $14.5M | 3.3% |
125,747
| – | – |
|
7
MediciNova
MNOV
$60.8M
| $7.01M | 1.6% |
1,170,370
| – | – |
|
|
8
Ligand Pharmaceuticals
LGND
$3.23B
| $3.28M | 0.75% |
49,687
-3,040
| -6% | -$201K |
|
|
ACUR
9
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $1.18M | 0.27% |
1,956,397
| – | – |
|
10
Gyre Therapeutics
GYRE
$718M
| $757K | 0.17% |
10,483
| – | – |
|